Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002577774 | SCV002946292 | benign | not provided | 2024-06-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003331375 | SCV004039379 | uncertain significance | not specified | 2023-08-24 | criteria provided, single submitter | clinical testing | Variant summary: FAM111A c.1477C>T (p.Arg493X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, however the molecular mechanism of disease attributed to FAM111A is gain-of-function. The variant allele was found at a frequency of 7.6e-05 in 251020 control chromosomes in the gnomAD database, including 1 homozygotes. To our knowledge, no occurrence of c.1477C>T in individuals affected with Autosomal Dominant Kenny-Caffey Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |